[Treatment of metastatic melanoma with interleukin-2].
Chosidow
O
O
Service de Dermatologie, Hôpital Henri-Mondor, Créteil.
Guillaume
J C
JC
D002945:Cisplatin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000494:pharmacology / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated; D016246:Lymphocytes, Tumor-Infiltrating; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary
D007376:Interleukin-2; D003606:Dacarbazine; D003520:Cyclophosphamide; D007372:Interferons; D002945:Cisplatin
Traitement du mélanome métastatique par l'interleukine-2.